steganacin has been researched along with colchicine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kupchan, SM; Rebhum, LI; Wang, RW | 1 |
| Horwitz, SB; Kende, AS; Schiff, PB | 1 |
| Gupta, RS | 1 |
| Burnett, JC; Day, BW; Gussio, R; Hamel, E; Hermone, AR; McGrath, C; Nguyen, TL; Wipf, P; Zaharevitz, DW | 1 |
4 other study(ies) available for steganacin and colchicine
| Article | Year |
|---|---|
Antimitotic and antitubulin activity of the tumor inhibitor steganacin.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Binding, Competitive; Cell Division; Colchicine; Cycloparaffins; Female; Glycoproteins; Lactones; Lignans; Microtubules; Mitosis; Ovum; Podophyllotoxin; Sea Urchins; Tubulin; Tubulin Modulators; Ultracentrifugation | 1977 |
Steganacin: an inhibitor of HeLa cell growth and microtubule assembly in vitro.
Topics: 4-Butyrolactone; Antineoplastic Agents, Phytogenic; Cell Division; Colchicine; Cycloparaffins; HeLa Cells; Lactones; Lignans; Microtubules; Mitotic Index; Protein Binding; Structure-Activity Relationship; Tubulin | 1978 |
Species-specific differences in toxicity of antimitotic agents toward cultured mammalian cells.
Topics: 4-Butyrolactone; Animals; Benzimidazoles; Biological Transport; Cells, Cultured; Colchicine; Cricetinae; Cricetulus; Griseofulvin; HeLa Cells; Humans; Lignans; Maytansine; Mice; Mitosis; Nocodazole; Podophyllotoxin; Species Specificity; Vinblastine | 1985 |
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
Topics: 2-Methoxyestradiol; 4-Butyrolactone; Aminophenols; Binding Sites; Chalcone; Colchicine; Cyclopropanes; Estradiol; Indans; Lignans; Models, Molecular; Molecular Structure; Nocodazole; Podophyllotoxin; Protein Binding; Stilbenes; Structure-Activity Relationship; Sulfonamides; Thiazoles; Tubulin; Tubulin Modulators | 2005 |